[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100179987":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":23,"responsibleParty":46,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":10,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":66,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Registry",null,"Patients with peritoneal carcinomatosis of colorectal origin, patients with pseudomyxoma peritonei (type DPAM or PMCA) and patients with peritoneal mesothelioma who are planned to undergo cytoreductive surgery and HIPEC because of a peritoneal surface malignancy",[13],{"name":14,"affiliation":15,"role":16},"André JL D'Hoore, PhD","University Clinics Gasthuisberg Department of Abdominal Surgery","PRINCIPAL_INVESTIGATOR",[18],{"name":19,"role":20,"phone":21,"phoneExt":10,"email":22},"Isabelle B Terrasson","CONTACT","+32 16 340837","isabelle.terrasson@uzleuven.be",[24],{"facility":25,"status":26,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"University Clinics Gasthuisberg","RECRUITING","Leuven","Flemish Brabant","3000","Belgium","BE",{"type":33,"coordinates":34},"Point",[35,36],4.70093,50.87959,{"lat":36,"lon":35},[39,40,44],{"name":19,"role":20,"phone":21,"phoneExt":10,"email":22},{"name":41,"role":20,"phone":42,"phoneExt":10,"email":43},"Daphne Hompes, MD","+32 16 341826","daphne.hompes@uzleuven.be",{"name":45,"role":16,"phone":10,"phoneExt":10,"email":10},"André JL D'HOORE, PhD",{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100179987","register-with-patients-in-which-hyperthermic-intra-peritoneal-chemotherapy-hipec-was-performed-100179987",false,"NCT01617382","Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed","Register With Data From Patients With the Diagnosis of a Peritoneal Surface Malignancy, for Which Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) is Performed","HIPEC","Inclusion Criteria:\n\n* Patients with peritoneal carcinomatosis of colorectal origin, patients with pseudomyxoma peritonei (type DPAM or PMCA) and patients with peritoneal mesothelioma who are planned to undergo cytoreductive surgery and HIPEC because of a peritoneal surface malignancy","ALL",{"count":58,"type":59},125,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC.",[63,64,65],"Peritoneal Carcinomatosis","Pseudomyxoma Peritonei","Peritoneal Mesothelioma",[54,67],"Hyperthermic (heated) chemotherapy after debulking","2024-06-25",{"date":70,"type":71},"2024-06-26","ACTUAL",{"date":73,"type":10},"2012-05",{"date":75,"type":59},"2028-12",{"name":5,"class":6},1]